Northwest Biotherapeutics closes registered direct placement of $12.6M

NewsGuard 100/100 Score
Editorial Checklist Reviewed
Dec 26 2015Northwest Biotherapeutics

Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing DCVax® personalized immune therapies for solid tumor cancers, today announced the closing of its previously-announced registered direct placement with healthcare focused institutional investors, for gross proceeds of $12.6 million on the terms previously announced.

H.C. Wainwright & Co., LLC acted as the exclusive placement agent for the transaction.

Source:

Northwest Biotherapeutics

Posted in: Business / Finance

Tags: , , , , , , , , , , , , , , , , ,

Comments (0)

Suggested Reading

Non-invasive detection and treatment of ovarian cancer with new radiotheranostic system
Obesity and high-fat diets linked to accelerated aging in brain blood vessels
The whey to go: Researchers unlock the potential of whey-derived proteins for cancer prevention
Feeling lonely? It may affect how your brain reacts to food, new research suggests
Does IBD affect cancer risk?
Lancet Commission predicts sharp increase in global prostate cancer cases
Study reveals skin bacteria removal boosts brain attention signals
Dartmouth-led research identifies unique brain areas for emotion regulation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
(Logout)
Post

Newsletters you may be interested in

See all Newsletters »

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback

You might also like...
ULB research unveils unprecedented mechanism of brain blood vessel formation